Filing Flows › Scientist Home Future Health (SHFH) › Q2 2025
Scientist Home Future Health (SHFH) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
Scientist Home Future Health (SHFH) reported revenue of $32K for the second quarter 2025 (Q2 2025) and -30% from the quarter before. Operating margin was -120.9%, net loss $37K (117.9% of revenue).
Scientist Home Future Health, Q2 2025: revenue $32K, operating margin -120.9%, net loss $37K, operating cash flow −$5K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32K | -30% | — |
| Operating profit | −$38K | -645% | — |
| Net earnings | −$37K | -714% | — |
| Operating cash flow | −$5K | — | — |
What changed
Revenue was $32K in Q2 2025, down 30% from the previous quarter. Scientist Home Mixed Gelatine Hydrolysate was the largest line at 39% of revenue.
Gross margin was 42.9%. Operating costs exceeded revenue by $38K, an operating margin of -120.9%. The quarter ended with a net loss of $37K, after a profit of $6K the previous quarter.
Operating cash flow was −$5K. Working capital and other items added $32K.
Questions
What was Scientist Home Future Health's revenue in the second quarter 2025?
Scientist Home Future Health (SHFH) reported revenue of $32K for the second quarter 2025 (Q2 2025) and -30% from the quarter before.
Was Scientist Home Future Health profitable in the second quarter 2025?
Operating loss was $38K (-120.9% of revenue) and net loss $37K.